Revance Therapeutics (NASDAQ:RVNC) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report released on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, Needham & Company LLC restated a “hold” rating on shares of Revance Therapeutics in a research note on Friday, January 17th. Nine research […]
StockNews.com initiated coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report released on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, Needham & Company LLC restated a “hold” rating on shares of Revance Therapeutics in a research note on Friday, January 17th. Nine research […]
